These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10576659)

  • 1. A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients.
    Huuhtanen RL; Wiklund TA; Blomqvist CP; Böhling TO; Virolainen MJ; Tribukait B; Andersson LC
    Br J Cancer; 1999 Nov; 81(6):1017-21. PubMed ID: 10576659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
    J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
    Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma.
    Schütte J; Mouridsen HT; Steward W; Santoro A; van Oosterom AT; Somers R; Blackledge G; Verweij J; Dombernowsky P; Thomas D
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S204-9. PubMed ID: 8453699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
    Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
    J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Soft tissue sarcoma: postoperative chemotherapy].
    Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Li EX; Zhang YT; Shang JT; Xu Z; Geng Y; Li SM; Shi F; Wu YY
    Ai Zheng; 2006 Aug; 25(8):1048-51. PubMed ID: 16965692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
    Demetri GD; Elias AD
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH; Wen XP; Hu L
    Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological changes after chemotherapy of soft tissue sarcomas in the adult].
    Coindre JM; Nguyen BB; Goussot JF; de Mascarel I; Maree D; de Mascarel A; Trojani M
    Ann Pathol; 1985; 5(2):95-9. PubMed ID: 3840024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
    Pápai Z; Bodoky G; Szántó J; Poller I; Rahóty P; Eckhardt S; Láng I; Szendroi M
    Cancer; 2000 Jul; 89(1):177-80. PubMed ID: 10897015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas.
    Comandone A; Bretti S; Bertetto O; Oliva C; Bergnolo P; Bumma C
    Anticancer Res; 2000; 20(3B):2077-80. PubMed ID: 10928155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
    Meric F; Hess KR; Varma DG; Hunt KK; Pisters PW; Milas KM; Patel SR; Benjamin RS; Plager C; Papadopoulos NE; Burgess MA; Pollock RE; Feig BW
    Cancer; 2002 Sep; 95(5):1120-6. PubMed ID: 12209699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness.
    Huuhtanen RL; Blomqvist CP; Böhling TO; Wiklund TA; Tukiainen EJ; Virolainen M; Tribukait B; Andersson LC
    Cancer Res; 1999 Jun; 59(12):2885-90. PubMed ID: 10383150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.